Chenfang Dong

Zhejiang Cancer Hospital — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

26h-index4.2kcitations82works2.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prion Diseases and Protein Misfolding(22), Trace Elements in Health(15), Cancer Cells and Metastasis(13), Lung Cancer Treatments and Mutations(13), HER2/EGFR in Cancer Research(13)

Publications81 total

RHOA lactylation at oncogenic hotspots promotes oncogenic activity and protein stabilization
Molecular Cancer·2025· 1 citedOpen Access
Acetylation suppresses breast cancer progression by sustaining CLYBL stability
Journal of Translational Medicine·2025· 1 citedOpen Access
RHOA lactylation at oncogenic hotspots promotes oncogenic activity and protein stabilization
Figshare·2025Open Access
RHOA lactylation at oncogenic hotspots promotes oncogenic activity and protein stabilization
Figshare·2025Open Access
Additional file 1 of RHOA lactylation at oncogenic hotspots promotes oncogenic activity and protein stabilization
Figshare·2025Open Access
Additional file 1 of RHOA lactylation at oncogenic hotspots promotes oncogenic activity and protein stabilization
Figshare·2025Open Access
AMD1 promotes breast cancer aggressiveness via a spermidine-eIF5A hypusination-TCF4 axis
Breast Cancer Research·2024· 12 citedOpen Access
Superbinder based phosphoproteomic landscape revealed PRKCD_pY313 mediates the activation of Src and p38 MAPK to promote TNBC progression
Cell Communication and Signaling·2024· 8 citedOpen Access
IMPA2 promotes basal-like breast cancer aggressiveness by a MYC-mediated positive feedback loop
Cancer Letters·2023· 6 cited
STNM1 in human cancers: role, function and potential therapy sensitizer
Cellular Signalling·2023· 19 citedOpen Access
Combination of novel oncolytic herpesvirus with paclitaxel as an efficient strategy for breast cancer therapy
Journal of Medical Virology·2023· 19 citedOpen Access
Supplementary Figures S1-S6 from Activation of the Aryl Hydrocarbon Receptor Leads to Resistance to EGFR TKIs in Non–Small Cell Lung Cancer by Activating Src-mediated Bypass Signaling
2023Open Access
Table S4 from Activation of the Aryl Hydrocarbon Receptor Leads to Resistance to EGFR TKIs in Non–Small Cell Lung Cancer by Activating Src-mediated Bypass Signaling
2023Open Access
Table S2 from Activation of the Aryl Hydrocarbon Receptor Leads to Resistance to EGFR TKIs in Non–Small Cell Lung Cancer by Activating Src-mediated Bypass Signaling
2023Open Access
Table S4 from Activation of the Aryl Hydrocarbon Receptor Leads to Resistance to EGFR TKIs in Non–Small Cell Lung Cancer by Activating Src-mediated Bypass Signaling
2023Open Access
Table S3 from Activation of the Aryl Hydrocarbon Receptor Leads to Resistance to EGFR TKIs in Non–Small Cell Lung Cancer by Activating Src-mediated Bypass Signaling
2023Open Access
Data from Activation of the Aryl Hydrocarbon Receptor Leads to Resistance to EGFR TKIs in Non–Small Cell Lung Cancer by Activating Src-mediated Bypass Signaling
2023Open Access
Table S1 from Activation of the Aryl Hydrocarbon Receptor Leads to Resistance to EGFR TKIs in Non–Small Cell Lung Cancer by Activating Src-mediated Bypass Signaling
2023Open Access
Data from Activation of the Aryl Hydrocarbon Receptor Leads to Resistance to EGFR TKIs in Non–Small Cell Lung Cancer by Activating Src-mediated Bypass Signaling
2023Open Access
Table S1 from Activation of the Aryl Hydrocarbon Receptor Leads to Resistance to EGFR TKIs in Non–Small Cell Lung Cancer by Activating Src-mediated Bypass Signaling
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Xiao‐Ping Dong(20), Jun Han(17), Qi Shi(12), Guirong Wang(11), Ruocen Liao(10), Bing Shan(10), Qianhua Cao(9), Song Shi(9), Run An(9), Chen Gao(9), Binhua P. Zhou(8), Xuebiao Wu(8), Jianming Chen(8), Baoyun Zhang(8), Chan Tian(8), Yanjun Lei(8), Xingyu Chen(7), Xiaoli Li(7), Hui-Ying Jiang(6), Yadi Wu(5)